Literature DB >> 8067714

Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases.

M Paganuzzi1, M Onetto, M de Paoli, M Castagnola, L de Salvo, D Civalleri, C E Grossi.   

Abstract

It has been suggested that bile CEA levels could represent a sensitive index for the detection of occult liver metastases in colorectal cancer (CRC) patients. We measured serum and gallbladder bile CEA concentrations in a control group, in a group of patients with benign disease of the biliary tree, and in patients with CRC at different stages. Neoplastic patients without evidence of liver metastases at the time of laparotomy, but with elevated biliary CEA levels, were selected for a follow-up study. Our results indicate that (a) bile CEA levels are falsely increased in several benign biliary diseases; (b) CRC patients with detectable liver metastases have elevated biliary CEA levels; (c) high biliary CEA levels do not represent a predictive parameter for the presence of occult liver metastases in CRC patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067714

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

Review 1.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

2.  Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?

Authors:  Giovanni Li Destri; Raffaele Lanteri; Marco Santangelo; Benedetto Torrisi; Antonio Di Cataldo; Stefano Puleo
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

3.  Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.

Authors:  Andrea L Small-Howard; Holden Harris
Journal:  J Immunoassay Immunochem       Date:  2010

4.  Biliary carcinoembryonic antigen levels in diagnosis of occult hepatic metastases from colorectal carcinoma.

Authors:  Jaques Waisberg; Rogério T Palma; Luís Contim Neto; Lourdes C Martins; Maurício S L Oliveira; Carlos A Nagashima; Antonio C Godoy; Fabio S Goffi
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen - a prospective study.

Authors:  S Bhattacharjya; R Aggarwal; B R Davidson
Journal:  Br J Cancer       Date:  2006-07-03       Impact factor: 7.640

6.  Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.

Authors:  Bilal Alaiyan; Nadia Ilyayev; Alexander Stojadinovic; Mina Izadjoo; Marina Roistacher; Vera Pavlov; Victoria Tzivin; David Halle; Honguang Pan; Barry Trink; Ali O Gure; Aviram Nissan
Journal:  BMC Cancer       Date:  2013-04-17       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.